| payload |
{"created_at":"2026-04-22T03:03:32.063 {"created_at":"2026-04-22T03:03:32.063787+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:33eb00255e0dc60f","evidence_event_ids":["evt_cd551efef04c"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","company":"QHSLab, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_0a210b469b27f6c5","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:15:02.146753+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt","source_event_id":"evt_cd551efef04c","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"a4fd33feb0c2720b","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-21","2026-04-22"],"entities":[{"asset_class":"equity","name":"QHSLab, Inc.","relevance":"high","symbol":"USAQ","type":"issuer"},{"asset_class":"other","name":"OTCQB","relevance":"medium","symbol":"OTCQB","type":"market"},{"asset_class":"other","name":"Q-Connect GLP-1 Support Assessment","relevance":"medium","symbol":"","type":"product/initiative"},{"asset_class":"other","name":"Integrated Service Program (ISP)","relevance":"high","symbol":"","type":"business program"},{"asset_class":"other","name":"Q-Connect AOM","relevance":"medium","symbol":"","type":"product/initiative"},{"asset_class":"other","name":"GLP-1","relevance":"medium","symbol":"","type":"drug class"}],"event_type":"earnings","information_gaps":["What changed vs prior known state is not explicitly described in the provided text beyond the press-release comparison of Q1 2026 vs Q1 2025.","No additional financial statements, guidance, or forward-looking financial targets are included in the provided excerpt.","The specific content of the \u201cearly second quarter 2026 update\u201d beyond the Q1 2026 ISP revenue and launch statements is not detailed in the excerpt.","No prior-period baseline other than Q1 2025 ISP revenue ($163,000) is provided for comparison."],"key_facts":["The company filed a Form 8-K with Item 7.01 Regulation FD Disclosure.","On April 21, 2026, QHSLab issued a press release titled \u201cQHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment.\u201d","The press release is furnished as Exhibit 99.1 to the 8-K.","Exhibit 99.1 states unaudited Q1 2026 ISP revenue of approximately $370,000 versus $163,000 in Q1 2025.","Exhibit 99.1 states the increase was $207,000, representing 127% year-over-year growth.","Exhibit 99.1 attributes growth to expanding provider adoption, the launch of the Q-Connect AOM and GLP-1 Support Assessment, and continued development of personalized cardiometabolic health journeys.","Exhibit 99.1 states platform expansion into metabolic and behavioral health strengthens patient engagement and broadens recurring care opportunities."],"numeric_claims":[{"label":"Q1 2026 unaudited ISP revenue","value":"~$370,000"},{"label":"Q1 2025 ISP revenue","value":"$163,000"},{"label":"Dollar increase","value":"$207,000"},{"label":"Year-over-year growth","value":"127%"}],"primary_claim":"In Q1 2026, QHSLab reported unaudited ISP revenue of approximately $370,000 versus $163,000 in Q1 2025, an increase of $207,000 (127% year-over-year).","relevance_score":0.72,"sentiment":"positive","source_quality":"high","summary":"QHSLab, Inc. filed a Form 8-K to disclose (via Regulation FD) an April 21, 2026 press release about growth in its Integrated Service Program (ISP) and the launch of Q-Connect GLP-1 support assessment. The filing includes Exhibit 99.1 with unaudited Q1 2026 ISP revenue results.","topics":["SEC filing","Form 8-K","Regulation FD disclosure","ISP revenue","Q-Connect launch","GLP-1 support assessment","digital health"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 QHSLab, Inc. \u00b7 Filed 20260421","ticker":"USAQ","tickers":["USAQ"],"title":"USAQ filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-018222.txt"}}... |